NEWARK, DE / ACCESSWIRE / March 21, 2023 / The HIV/HBV/HCV test kits market size is projected to be valued at US$ 6,568.3 million in 2023 and is expected to rise to US$ 11,573.9 million by 2033. The sales of HIV/HBV/HCV test kits are expected to grow at a significant CAGR of 5.8% during the forecast period. The global incidence of HIV and hepatitis has increased significantly, and this is expected to drive HIV/HBV/HCV test kit consumption. With HIV and hepatitis infections being major public health issues around the world, there is a high demand for effective diagnostic services for these diseases. According to the WHO''s June 2022 report, an estimated 58 million people worldwide have chronic hepatitis C virus infection, with approximately 1.5 million new cases occurring each year. An estimated 3.2 million adolescents and children are infected with chronic hepatitis C. The disease''s high prevalence is expected to drive market growth. Get a holistic overview of the market from industry experts to evaluate and develop growth strategies.

Siemens Healthineers, leader in advanced medical technology for more than 125 years, designates its first reference and training centre: Ovidius Clinical Hospital, the biggest multidisciplinary private hospital in Southeast Romania. Ovidius Clinical Hospital becomes the first medical site in the country to benefit from equipment and technologies provided exclusively by Siemens. This partnership starts in the context of the extension of the hospital in Ovidiu, Constanța County, at the beginning of April, with two dedicated oncology and cardiology centres, the result of the largest private investment in the health field in Southeast Romania since 1989: 28 million euros. “This partnership and the designation of Ovidius Clinical Hospital as Siemens Healthineers reference centre is truly a national first where the medical centre fully benefits from Siemens Healthineers equipment and technology, which significantly contributes to providing high quality medical services. Thus, the two new centres that expand Ovidius Clinical Hospital starting this April – the oncology and radiotherapy as well as interventional cardiology and cardiovascular surgery one – will incorporate, as a result of this strategic partnership, the latest innovations, and medical technologies that Siemens Healthineers brings to Romania”, said Dr.

Healthcare - Siemens Healthineers, leader in advanced medical technology for more than 125 years, designates its first reference and training centre: Ovidius Clinical

Ovidius Clinical Hospital, the largest multidisciplinary private hospital in South-East Romania, becomes the first Siemens Healthineers Reference and Training Centre in Romania. At the same time, the hospital in Ovidiu is expanding in early April with a new hospital building in which the two dedicated centres for oncology, radiotherapy, interventional cardiology, and cardiovascular surgery will operate. This development is the result of the largest private investment in healthcare in South-East Romania since 1989: €28 million. This collaboration is an important step for the development of the Romanian healthcare system, as well as an opportunity for Ovidius Clinical Hospital to offer patients access to the most advanced medical technologies. The reality of Dobrogea is aligned with that of the whole of Romania: cardiovascular and oncological diseases are at the top of the list in terms of incidence and increase in the number of cases, so naturally we are extending our work towards real needs, as we have done from day one.

According to the most recent USD Analytics analysis, the worldwide “3d Medical Imaging Equipment Market” is expected to grow at a CAGR of 4.9% during the forecast period 2023-2030. Hyderabad, India -- ( SBWIRE ) -- 03/01/2023 -- Three-dimensional (3D) medical imaging equipment plays an essential role in modern healthcare. It is used to obtain detailed images of internal organs, tissues, and bones, which helps in the accurate diagnosis and treatment of various diseases. These imaging technologies offer high-resolution images, which allow clinicians to identify abnormalities and potential health problems that are often difficult to detect using traditional 2D imaging techniques. As a result, the 3D medical imaging equipment market has been growing rapidly over the past few years, and this trend is expected to continue in the coming years. Market Size and Future Apprehension: According to the most recent USD Analytics analysis, the worldwide "3d Medical Imaging Equipment Market" is expected to grow at a CAGR of 4.9% during the forecast period 2023-2030.

Siemens Healthineers shares look 15% to 25% undervalued today. Click here to read my analysis of SMMNY stock.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 28.02.2023 / 18:39 CET/CEST The issuer is solely responsible for the content of this announcement. 1. Details of the person discharging managerial responsibilities / person closely associated

Siemens Healthineers employs almost 7000 people in India, and more than 3200 of them are software and digital experts

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 23.02.2023 / 18:18 CET/CEST The issuer is solely responsible for the content of this announcement. 1. Details of the person discharging managerial responsibilities / person closely associated

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 22.02.2023 / 18:51 CET/CEST The issuer is solely responsible for the content of this announcement. 1. Details of the person discharging managerial responsibilities / person closely associated

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 22.02.2023 / 18:51 CET/CEST The issuer is solely responsible for the content of this announcement. 1. Details of the person discharging managerial responsibilities / person closely associated a) Name Title: First name: Elisabeth Last name(s): Staudinger-Leibrecht 2. Reason for the notification a) Position / status Position: Member of the managing body b) Initial notification 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Siemens Healthineers AG b) LEI 529900QBVWXMWANH7H45 4. Details of the transaction(s) a) Description of the financial instrument, type of instrument, identification code Type: Share ISIN: DE000SHL1006 b) Nature of the transaction Purchase of Siemens Healthineers shares in the amount of EUR 22,567.43 (less taxes and contributions) as an automatic reinvestment of dividends (in connection with Siemens Healthineers share programs) for the following price: Volume Weighted Average Price for all Siemens Healthineers shares which were acquired for the beneficiaries of the Siemens Healthineers share programs by means of dividend reinvestment within three trading days after receipt of the dividend.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 22.02.2023 / 18:46 CET/CEST The issuer is solely responsible for the content of this announcement. 1. Details of the person discharging managerial responsibilities / person closely associated

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 22.02.2023 / 18:46 CET/CEST The issuer is solely responsible for the content of this announcement. 1. Details of the person discharging managerial responsibilities / person closely associated a) Name Title: Dr. First name: Jochen Last name(s): Schmitz 2. Reason for the notification a) Position / status Position: Member of the managing body b) Initial notification 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Siemens Healthineers AG b) LEI 529900QBVWXMWANH7H45 4. Details of the transaction(s) a) Description of the financial instrument, type of instrument, identification code Type: Share ISIN: DE000SHL1006 b) Nature of the transaction Purchase of Siemens Healthineers shares in the amount of EUR 46,532.15 (less taxes and contributions) as an automatic reinvestment of dividends (in connection with Siemens Healthineers share programs) for the following price: Volume Weighted Average Price for all Siemens Healthineers shares which were acquired for the beneficiaries of the Siemens Healthineers share programs by means of dividend reinvestment within three trading days after receipt of the dividend.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 22.02.2023 / 18:40 CET/CEST The issuer is solely responsible for the content of this announcement. 1. Details of the person discharging managerial responsibilities / person closely associated

New Delhi [India], February 22 (ANI/BusinessWire India): Terumo India, the Indian arm of Terumo Corporation (TSE: 4543), has partnered with Siemens Healthineers, to introduce a first-of-its-kind programme for Cathlab Directors aimed at building standards of care and enhancing efficiency in Cathlabs across India, in collaboration with Executive Education at the Indian School of Business (ISB ExecEd), a globally top-ranked business school.

New Delhi, Delhi, India: Terumo India, the Indian arm of Terumo Corporation (TSE: 4543), has partnered with Siemens Healthineers, to introduce a first-of-its-kind programme for […] The post Terumo India Partners with Siemens Healthineers to Introduce First of Its Kind Programme for Cathlab Directors in Collaboration with ISB Executive Education appeared first on Businessfortnight .

More than 14,000 verified attendees attended the five-in-one co-located expo that featured automation technology, medical design, packaging, plastics, and design and manufacturing. ANAHEIM, CA / ACCESSWIRE / February 21, 2023 / The largest manufacturing trade show on the West Coast reports a 26% increase in attendance for its 2023 expo compared to last year with more than 14,000 verified attendees visiting the Anaheim Convention Center in Anaheim , California , from Feb. 7-9 . Registrants from all 50 states in the U.S. and an additional 100 countries were present on the show floor, which covered 320,000 net square feet. The expo hosted more than 1,600 exhibitors, producing a 14% increase in booths compared to 2022 across co-locates Medical Design & Manufacturing (MD&D) West , WestPack , Plastec West , Design & Manufacturing (D&M) West and ATX West . Top-tier and consumer household brands such as Alcon , Amazon , Becton Dickinson , Bose , Cardinal Health , Herbalife , SpaceX , Intuitive Surgical , Johnson & Johnson , Mattel , Nike , Medtronic , Norton Packaging , Siemens Healthineers and Stryker all convened under one roof for the three-day show. "Having a vast increase in overall attendance and exhibitors from last year shows that manufacturing continues to grow and affect consumers in innovation, productivity and trade, especially with West Coast brands such as Amazon and Nike contributing to the manufacturing conversation," says Adrienne Zepeda, Group Event Director. "For every dollar spent in manufacturing, there is a total impact of $2.60 to the overall U.S. economy , making the industry one of the largest sectoral multipliers in our economy as it continues to rely more heavily on service inputs .

Immunodiagnostics specialist Oncimmune announced a collaboration with Siemens Healthineers on Friday, to improve malignancy risk assessment of indeterminate pulmonary nodules (IPNs).

Newark, New Castle, USA: Growth Plus Reports recently introduced a new title on Hepatitis C Testing Market 2022 and forecast 2030 from its database. The Hepatitis C Testing report provides a study with an in-depth overview, describing the product/industry scope

Healthcare Information Software Market May See a Big Move NJ New Jersey, USA -- ( SBWIRE ) -- 02/07/2023 -- Advance Market Analytics published a new research publication on "Healthcare Information Software Market Insights, to 2027" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Healthcare Information Software market was mainly driven by the increasing R&D spending across the world. Get Free Exclusive PDF Sample Copy of This Research @ https://www.advancemarketanalytics.com/sample-report/1632-global-healthcare-information-software-market Some of the key players profiled in the study are: GE Healthcare (United States), Siemens Healthcare (Germany), 3M Health (United States), McKesson (United States), Philips Healthcare (United States), Agfa Gevaert (Belgium), Allscripts (United States), Dell (United States), Epic Systems (United States), NextGen Healthcare (United States),.

https://www.investing.com/news/pro/siemens-healthineers-ag-pt-lowered-to-eur49-at-jefferies-432SI-2995815

https://www.investing.com/news/pro/berenberg-reiterates-buy-rating-on-siemens-healthineers-432SI-2995759

https://www.investing.com/news/pro/siemens-healthineers-ag-pt-raised-to-eur58-at-morgan-stanley-432SI-2994822

The following slide deck was published by Siemens Healthineers AG in conjunction with their 2023 Q1 earnings call.

Siemens Healthineers AG (OTCPK:SEMHF) Q1 2023 Earnings Conference Call February 2, 2023 2:30 AM ETCompany ParticipantsMarc Koebernick - Head of Investor RelationsBernd Montag - Chief…

Siemens Healthineers AG (SEMHF): Q1 Non-GAAP EPS of €0.47.Revenue of €5.07B (+0.2% Y/Y).Press release

BERLIN (Reuters) – Siemens Healthineers confirmed its full-year outlook on Thursday despite a drop in quarterly profit driven by low demand in…

Siemens Healthineers AG (SMMNY.PK) reported that its first quarter adjusted EBIT fell by 28% to 647 million euros, translating into a lower adjusted EBIT margin of 12.7%. The company said this was against the backdrop of a lower contribution from rapid COVID-19 antigen tests, cost increases - particularly for procurement and

BERLIN (Reuters) -Siemens Healthineers reported a 28% drop in quarterly operating profit due to lower sales of rapid COVID-19 antigen tests and delays at a supplier of its Varian business.

WILMINGTON, DE / ACCESSWIRE / January 30, 2023 / Transparency Market Research Inc. - The increase in intensive care admissions for respiratory infections in developing and developed countries is propelling the adoption of intensive care unit (ICU) ventilators. The global intensive care unit (ICU) ventilators market is projected to surpass US$ 3.9 Bn by 2031. The surge in the usage of ICU ventilators among patients with COVID-19-related complications has augmented market size. The introduction of high-end ICU ventilators is expected to accelerate the intensive care unit (ICU) ventilators market development. Products that are portable, easy to use, and allow clinicians to monitor pressure, volume, and flow in real-time are gaining traction in various healthcare settings. Additionally, technologically advanced ventilators are equipped with smart algorithms that will help boost patient outcomes. The utilization of high-end ICU ventilators has increased in out-of-hospital settings, including the usage of home ventilation for critically ill patients.

SAMEER, India''s premier R&D Institute of Ministry of Electronics and IT (MeitY) signed a memorandum of understanding with Siemens Healthineers that will contribute towards the development of new, improved and innovative technologies for advancing healthcare and diagnostic access in India, in Bengaluru. The Minister of State for Electronics & Information Technology and Skill Development &Entrepreneurship,…

The minister emphasised that Digital India Programme launched by the Prime Minister in 2015 has paved way for the nation to move from being a consumer of technology to a producer of technology, devices and products.

The MoU today is a significant step in this direction, Chandrasekhar said.He also observed the healthcare sector in India represents a big market and added that the government is prepared to partner with global companies who are willing to set up manufacturing bases in India.

The ministry of electronics and information technology (MeitY) and Siemens Healthineers signed a memorandum of understanding (MoU) to offer advanced healthcare and diagnostic access in India. For this initiative, Siemens Healthineers is partnering with the Society for Applied Microwave Electronics Engineering & Research (SAMEER), a premier research and development institute under MeitY.

New Delhi, Delhi, India: Focus on joint Healthcare providers’ training and education initiatives and innovative programs for physicians First-of-its-kind Cathlab Director Program […] The post Terumo and Siemens Healthineers India Collaborate to Strengthen Cardiac Care in India appeared first on Businessfortnight .